ATE428470T1 - Heilmittel zur behandlung von erkrankungen des sehnervs - Google Patents

Heilmittel zur behandlung von erkrankungen des sehnervs

Info

Publication number
ATE428470T1
ATE428470T1 AT01945674T AT01945674T ATE428470T1 AT E428470 T1 ATE428470 T1 AT E428470T1 AT 01945674 T AT01945674 T AT 01945674T AT 01945674 T AT01945674 T AT 01945674T AT E428470 T1 ATE428470 T1 AT E428470T1
Authority
AT
Austria
Prior art keywords
optic nerve
remedies
treating diseases
medicament
therapeutic
Prior art date
Application number
AT01945674T
Other languages
English (en)
Inventor
Tomiya Mano
Shunji Sogou
Eri Inoue
Original Assignee
Mei Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mei Co Ltd filed Critical Mei Co Ltd
Application granted granted Critical
Publication of ATE428470T1 publication Critical patent/ATE428470T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
AT01945674T 2000-06-29 2001-06-28 Heilmittel zur behandlung von erkrankungen des sehnervs ATE428470T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000197250 2000-06-29
PCT/JP2001/005585 WO2002000260A1 (fr) 2000-06-29 2001-06-28 Jp0105585atif contre des maladies du nerf optique et analogue

Publications (1)

Publication Number Publication Date
ATE428470T1 true ATE428470T1 (de) 2009-05-15

Family

ID=18695597

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01945674T ATE428470T1 (de) 2000-06-29 2001-06-28 Heilmittel zur behandlung von erkrankungen des sehnervs

Country Status (8)

Country Link
US (2) US20030109566A1 (de)
EP (1) EP1297849B1 (de)
JP (1) JPWO2002000260A1 (de)
AT (1) ATE428470T1 (de)
AU (1) AU2001267864A1 (de)
CA (1) CA2414586C (de)
DE (1) DE60138385D1 (de)
WO (1) WO2002000260A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1525856A (zh) * 2001-05-11 2004-09-01 三菱制药株式会社 含吡唑啉酮衍生物的稳定的高浓度注射剂
MXPA04011416A (es) 2002-05-17 2005-09-30 Othera Pharmaceuticals Inc Mejora del desarrollo de las cataratas y otras enfermedades oftalmicas.
AU2002344454A1 (en) * 2002-11-05 2004-06-07 Lead Chemical Co., Ltd. Percutaneous absorption preparations containing 3-methyl-1-phenyl-2-pyrazolin-5-one
US7825134B2 (en) 2003-05-19 2010-11-02 Othera Holding, Inc. Amelioration of cataracts, macular degeneration and other ophthalmic diseases
JP2007527417A (ja) * 2003-11-20 2007-09-27 オセラ・フアーマシユーチカルズ・インコーポレーテツド 白内障、黄斑変性および他の眼疾患の改善
WO2007055312A1 (ja) * 2005-11-10 2007-05-18 Mitsubishi Tanabe Pharma Corporation ピラゾロン化合物含有水溶液が充填されたプラスチック容器
BRPI0815597A2 (pt) * 2007-11-21 2014-09-30 Teikoku Pharma Usa Inc Formulações de emulsões com derivado de pirazolona
WO2010087306A1 (ja) 2009-01-29 2010-08-05 株式会社林原生物化学研究所 抗神経変性疾患剤
JP2017222575A (ja) 2014-09-19 2017-12-21 田辺三菱製薬株式会社 眼科疾患予防治療剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3533662A1 (de) * 1984-09-20 1986-03-27 Medice Chem.-Pharm. Fabrik Pütter GmbH & Co KG, 5860 Iserlohn Kombination von 1-phenyl-4-alkylpyrazolidindion-3,5-derivaten mit einem starken reduktionsmittel fuer die herstellung eines topischen entzuendungshemmenden arzneimittels fuer augen
DK169672B1 (da) * 1985-05-20 1995-01-09 Mitsubishi Chem Ind Farmaceutiske præparater indeholdende pyrazolonderivater som aktiv bestanddel og anvendelsen af pyrazolonderivater til fremstilling af farmaceutiske præparater
JPS62108814A (ja) 1985-11-07 1987-05-20 Mitsubishi Chem Ind Ltd 過酸化脂質生成抑制剤
JPS61263917A (ja) 1985-05-20 1986-11-21 Mitsubishi Yuka Yakuhin Kk 脳機能正常化剤
FR2608045B1 (fr) 1986-12-12 1990-03-02 Chauvin Laboratoires Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome
JP2906512B2 (ja) * 1990-01-16 1999-06-21 三菱化学株式会社 抗潰瘍剤
WO1993000088A1 (de) * 1991-06-24 1993-01-07 Hoechst Aktiengesellschaft Verwendung von phenylpyrazolin-derivaten zur behandlung von erhöhtem augeninnendruck
TW325997B (en) * 1993-02-02 1998-02-01 Senju Pharma Co Pharmaceutical composition for preventing and treating retinal diseases
JPH0725765A (ja) * 1993-07-07 1995-01-27 Mitsubishi Chem Corp 眼疾患用薬剤
JPH09278652A (ja) * 1996-04-05 1997-10-28 Sumitomo Pharmaceut Co Ltd 網膜疾患治療剤
GB9701710D0 (en) * 1997-01-28 1997-03-19 Karobio Ab Mammalian protein
JPH10218771A (ja) * 1997-02-05 1998-08-18 Ishihara Sangyo Kaisha Ltd ピラゾロン系化合物またはその塩を含有する血小板由来血管内皮細胞増殖因子活性阻害剤

Also Published As

Publication number Publication date
US20060247293A1 (en) 2006-11-02
EP1297849A1 (de) 2003-04-02
CA2414586A1 (en) 2002-12-30
WO2002000260A1 (fr) 2002-01-03
DE60138385D1 (de) 2009-05-28
US7638516B2 (en) 2009-12-29
CA2414586C (en) 2009-09-29
US20030109566A1 (en) 2003-06-12
AU2001267864A1 (en) 2002-01-08
EP1297849B1 (de) 2009-04-15
EP1297849A4 (de) 2006-10-18
JPWO2002000260A1 (ja) 2004-01-08

Similar Documents

Publication Publication Date Title
ATE426413T1 (de) Verfahren und zusammensetzungen zur behandlung von okularer neovaskularisierung und nervenverletzungen
DE60101265D1 (de) Behandlung von augenschmerzen
ATE376828T1 (de) Verwendung von rotigotin zur behandlung und prävention des parkinson-plus-syndroms
BR0108175A (pt) Derivados de piperazina e piperidina para o tratamento ou a prevenção de danos neuronais
SE9803710D0 (sv) Use of certain drugs for treating nerve root injury
ATE445405T1 (de) Vorbeugung und behandlung von oxidativer-stress- erkrankungen mit verbindungen die den intrazellulären spiegel von glutathion oder phase-ii-entgiftungsenzymen erhöhen
DE60142839D1 (de) Botulinum Toxin zur Behandlung von akuten Verletzungen der Skelettmuskeln
BR0210241A (pt) Piranoindazóis e seu uso no tratamento de glaucoma
WO2004096216A3 (en) Use of a topical medicament comprising riluzole
ATE533486T1 (de) Verwendung von pyridonderivaten zur vorbeugung und behandlung von strahlungsbedingter lungenverletzung
EA200300560A1 (ru) Улучшенный способ лечения
DE60130872D1 (de) Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer
ATE435026T1 (de) Verfahren zur prävention und behandlung von diabetes mit neurturin
ATE428470T1 (de) Heilmittel zur behandlung von erkrankungen des sehnervs
ATE448779T1 (de) Methode zur behandlung trockener augen und uveitis
DE60231246D1 (de) Superoxiddismutas-mimetika zur behandlung von augenerkrankungen
BR9915569A (pt) Método para o tratamento de doenças neovasculares oculares
BR0113201A (pt) processo para tratar distúrbios neurodegenerativos da retina e da cabeça do nervo óptico
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
BR0309611A (pt) ácidos aminoalcanofosfÈnicos substituìdos para o tratamento da dor neuropática, dos distúrbios afetivos e da atenção, da esquizofrenia, do zumbido no ouvido, da miopia e de outros distúrbios oculares.
MXPA04001255A (es) Uso de compuesto para el tratamiento de condiciones que resultan de lesion al nervio corneo despues de lasik y otras cirugias oculares o trauma.
DE60231994D1 (de) Mittel zur behandlung oder prävention allergischerg
ATE291425T1 (de) R-eliprodil zur behandlung von glaucoma
BRPI0417549A (pt) miméticos de superóxido dismutase para o tratamento de lesão de nervo óptico e retinal
BR0215752A (pt) Piranoindazóis e seu uso no tratamento de glaucoma

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties